Semiautomated Workflow for Clinically Streamlined Glioma Parametric Response Mapping
Lauren Keith1, Brian D Ross2, Craig J Galbán2
1Imbio, LLC, Minneapolis, Minnesota.
Abstract:
Management of glioblastoma multiforme remains a challenging problem despite recent advances in targeted therapies. Timely assessment of therapeutic agents is hindered by the lack of standard quantitative imaging protocols for determining targeted response. Clinical response assessment for brain tumors is determined by volumetric changes assessed at 10 weeks post-treatment initiation. Further, current clinical criteria fail to use advanced quantitative imaging approaches, such as diffusion and perfusion magnetic resonance imaging. Development of the parametric response mapping (PRM) applied to diffusion-weighted magnetic resonance imaging has provided a sensitive and early biomarker of successful cytotoxic therapy in brain tumors while maintaining a spatial context within the tumor. Although PRM provides an earlier readout than volumetry and sometimes greater sensitivity compared with traditional whole-tumor diffusion statistics, it is not routinely used for patient management; an automated and standardized software for performing the analysis and for the generation of a clinical report document is required for this. We present a semiautomated and seamless workflow for image coregistration, segmentation, and PRM classification of glioblastoma multiforme diffusion-weighted magnetic resonance imaging scans. The software solution can be integrated using local hardware or performed remotely in the cloud while providing connectivity to existing picture archive and communication systems. This is an important step toward implementing PRM analysis of solid tumors in routine clinical practice.
Insights
Parametric response mapping (PRM) offers an early biomarker for glioblastoma treatment response. A new software workflow enables automated PRM analysis, advancing its clinical use for brain tumor management.
Area of Science:
- Neuro-oncology
- Medical Imaging
- Radiology
Background:
- Glioblastoma multiforme management is challenging, with limited quantitative imaging for treatment response assessment.
- Current clinical criteria rely on volumetric changes at 10 weeks, missing advanced quantitative imaging like diffusion MRI.
- Parametric response mapping (PRM) shows promise as an early, sensitive biomarker for cytotoxic therapy in brain tumors.
Purpose of the Study:
- To develop a standardized, automated software workflow for PRM analysis of glioblastoma diffusion-weighted MRI.
- To facilitate the integration of PRM into routine clinical practice for improved patient management.
Main Methods:
- A semiautomated workflow was developed for image coregistration, segmentation, and PRM classification.
- The software supports local hardware integration or cloud-based remote processing.
- Connectivity to existing picture archive and communication systems is provided.
Main Results:
- The developed workflow enables seamless PRM classification of glioblastoma diffusion-weighted MRI scans.
- The software provides a standardized approach for generating clinical reports.
- This represents a significant step towards routine clinical implementation of PRM.
Conclusions:
- The presented software workflow is crucial for the clinical adoption of PRM in glioblastoma management.
- Automated PRM analysis offers an earlier and potentially more sensitive assessment of treatment response compared to traditional methods.
- This advancement facilitates the use of advanced quantitative imaging in routine patient care for solid tumors.
More Related Videos
13:12Translational Brain Mapping at the University of Rochester Medical Center: Preserving the Mind Through Personalized Brain Mapping
Published on: August 12, 2019
09:09Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion
Published on: April 12, 2020
